Reported Aug 20, 2020 · Announced
Bayshore Pharmaceuticals, LLC recalls Bayshore Pharmaceuticals, LLC Metformin Hydrochloride Extended-Release Tablets USP, 500 mg & 750 mg due to Due to the…
Bayshore Pharmaceuticals, LLC
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
- Metformin Hydrochloride Extended-Release Tablets USP, 500
- mg & 750 mg BrandBayshore Pharmaceuticals, LLC. Drugs
Why it was recalled
Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Bayshore Pharmaceuticals, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.